Negara: Inggris
Bahasa: Inggris
Sumber: MHRA (Medicines & Healthcare Products Regulatory Agency)
Valsartan
Milpharm Ltd
C09CA03
Valsartan
80mg
Capsule
Oral
No Controlled Drug Status
Valid as a prescribable product
BNF: 02050502
Black VALSARTAN P15XXXXX VALSARTAN P15XXXXX READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. - Keep this leaflet. You may need to read it again. - If you have any further questions, ask your doctor or pharmacist. - This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. - If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet See section 4. WHAT IS IN THIS LEAFLET 1. What Valsartan is and what it is used for 2. What you need to know before you take Valsartan 3. How to take Valsartan 4. Possible side effects 5. How to store Valsartan 6. Contents of the pack and other information 1. WHAT VALSARTAN IS AND WHAT IT IS USED FOR Valsartan capsules belong to a class of medicines known as angiotensin II receptor antagonists, which help to control high blood pressure. Angiotensin II is a substance in the body that causes vessels to tighten, thus causing your blood pressure to increase. Valsartan capsules work by blocking the effect of angiotensin II. As a result, blood vessels relax and blood pressure is lowered. Valsartan 40 mg capsules CAN BE USED FOR THREE DIFFERENT CONDITIONS: • TO TREAT HIGH BLOOD PRESSURE IN CHILDREN AND ADOLESCENTS 6 TO 18 YEARS OF AGE. High blood pressure increases the workload on the heart and arteries. If not treated it can damage the blood vessels of the brain, heart, and kidneys, and may result in a stroke, heart failure, or kidney failure. High blood pressure increases the risk of heart attacks. Lowering your blood pressure to normal reduces the risk of developing these disorders. • TO TREAT ADULT PATIENTS AFTER A RECENT HEART ATTACK (myocardial infarction). “Recent” here means between 12 hours and 10 days. • Valsartan can be used to treat symptomatic heart failure in adult patients. Valsartan is used when a group of medicines called Angiotensi Baca dokumen lengkapnya
OBJECT 1 VALSARTAN 80 MG CAPSULES Summary of Product Characteristics Updated 07-Jun-2018 | Aurobindo Pharma - Milpharm Ltd. 1. Name of the medicinal product Valsartan 80 mg capsules, hard 2. Qualitative and quantitative composition Each hard capsule contains 80 mg of valsartan. For the full list of excipients, see section 6.1. 3. Pharmaceutical form Capsule, hard Opaque light grey cap / Flesh opaque body, size '3' hard gelatin capsules imprinted in black ink with 'I' on cap and '71' on body, filled with white to off white granular powder. 4. Clinical particulars 4.1 Therapeutic indications Hypertension Treatment of essential hypertension in adults, and hypertension in children and adolescents 6 to 18 years of age. Recent myocardial infarction Treatment of clinically stable adult patients with symptomatic heart failure or asymptomatic left ventricular systolic dysfunction after a recent (12 hours – 10 days) myocardial infarction (see sections 4.4 and 5.1). Heart failure Treatment of adult patients with symptomatic heart failure when ACE-inhibitors are not tolerated or in beta-blocker intolerant patients as add-on therapy to ACE-inhibitors when mineralocorticoid receptor antagonists cannot be used (see Sections 4.2, 4.4, 4.5 and 5.1). 4.2 Posology and method of administration Posology Hypertension The recommended starting dose of Valsartan is 80 mg once daily. The antihypertensive effect is substantially present within 2 weeks, and maximal effects are attained within 4 weeks. In some patients whose blood pressure is not adequately controlled, the dose can be increased to 160 mg and to a maximum of 320 mg. Valsartan may also be administered with other antihypertensive agents. The addition of a diuretic such as hydrochlorothiazide will decrease blood pressure even further in these patients (see Sections 4.3, 4.4, 4.5 and 5.1). Recent myocardial infarction In clinically stable patients, therapy may be initiated as early as 12 hours after a myocardial infarction. After an initial dose of 20 mg twice daily, valsartan Baca dokumen lengkapnya